As of 2:33pm ET
| +0.0168 / +2.57%|
The 4 analysts offering 12-month price forecasts for Cyclacel Pharmaceuticals Inc have a median target of 13.50, with a high estimate of 19.00 and a low estimate of 8.00. The median estimate represents a +1,911.62% increase from the last price of 0.67.
The current consensus among 4 polled investment analysts is to Buy stock in Cyclacel Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.